These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 29424981)

  • 41. Vaginal evisceration during pessary fitting and treatment with immediate colpocleisis.
    Rubin R; Jones KA; Harmanli OH
    Obstet Gynecol; 2010 Aug; 116 Suppl 2():496-498. PubMed ID: 20664431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness of ring pessaries versus vaginal hysterectomy for advanced pelvic organ prolapse. A cohort study.
    Miceli A; Dueñas-Diez JL
    Int Urogynecol J; 2019 Dec; 30(12):2161-2169. PubMed ID: 30863947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pessary types and discontinuation rates in patients with advanced pelvic organ prolapse.
    Wolff B; Williams K; Winkler A; Lind L; Shalom D
    Int Urogynecol J; 2017 Jul; 28(7):993-997. PubMed ID: 27942793
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Case series: Vaginal pessary for pelvic organ prolapse and its association with vaginal cancer.
    Tan ACC; Faiz MJ
    Med J Malaysia; 2021 Nov; 76(6):910-913. PubMed ID: 34806683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. What Are the Clinical Factors That Are Predictive of Persistent Pessary Use at 12 Months?
    Chan MC; Hyakutake M; Yaskina M; Schulz JA
    J Obstet Gynaecol Can; 2019 Sep; 41(9):1276-1281. PubMed ID: 30712905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of unsuccessful pessary fitting in women with prolapse: a cross-sectional study in general practice.
    Panman CM; Wiegersma M; Kollen BJ; Burger H; Berger MY; Dekker JH
    Int Urogynecol J; 2017 Feb; 28(2):307-313. PubMed ID: 27525693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaginal ring pessary use for pelvic organ prolapse: continuation rates and predictors of continued use.
    Manonai J; Sarit-Apirak S; Udomsubpayakul U
    Menopause; 2018 Dec; 26(6):665-669. PubMed ID: 30562318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of Local Estrogen Cream on Vaginal Health after Pessary Use for Prolapsed Pelvic Organ: A Randomized Controlled Trial.
    Tontivuthikul P; Sanmee U; Wongtra-Ngan S; Pongnarisorn C
    J Med Assoc Thai; 2016 Jul; 99(7):757-63. PubMed ID: 29901374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors associated with long-term pessary use in women with symptomatic pelvic organ prolapse.
    Mao M; Xu T; Kang J; Zhang Y; Ai F; Zhou Y; Zhu L
    Climacteric; 2019 Oct; 22(5):478-482. PubMed ID: 30897024
    [No Abstract]   [Full Text] [Related]  

  • 50. Female pelvic organ prolapse using pessaries: systematic review.
    de Albuquerque Coelho SC; de Castro EB; Juliato CR
    Int Urogynecol J; 2016 Dec; 27(12):1797-1803. PubMed ID: 26992725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and cost-effectiveness of vaginal pessary self-management compared to clinic-based care for pelvic organ prolapse: protocol for the TOPSY randomised controlled trial.
    Hagen S; Kearney R; Goodman K; Melone L; Elders A; Manoukian S; Agur W; Best C; Breeman S; Dembinsky M; Dwyer L; Forrest M; Graham M; Guerrero K; Hemming C; Khunda A; Mason H; McClurg D; Norrie J; Karachalia-Sandri A; Thakar R; Bugge C
    Trials; 2020 Oct; 21(1):837. PubMed ID: 33032644
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of a pessary in treatment of pelvic organ prolapse: quality of life, compliance, and failure at 1-year follow-up.
    Ko PC; Lo TS; Tseng LH; Lin YH; Liang CC; Lee SJ
    J Minim Invasive Gynecol; 2011; 18(1):68-74. PubMed ID: 21195956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A prospective study of pessary treatment for pelvic organ prolapse and health-related quality-of-life].
    Wang XQ; Zhu L; Li B; Tang X; Xu T
    Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(37):2982-5. PubMed ID: 24401590
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pessary treatment for pelvic organ prolapse and health-related quality of life: a review.
    Lamers BH; Broekman BM; Milani AL
    Int Urogynecol J; 2011 Jun; 22(6):637-44. PubMed ID: 21472447
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ring pessary for all pelvic organ prolapse.
    Manchana T
    Arch Gynecol Obstet; 2011 Aug; 284(2):391-5. PubMed ID: 20848116
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaginal pessary continuation in symptomatic pelvic organ prolapse patients with prior hysterectomy.
    Ma C; Kang J; Xu T; Zhang Y; Ma Y; Liang S; Hui Y; Wang Y; Zhu L
    Menopause; 2020 Oct; 27(10):1148-1154. PubMed ID: 32881830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quality of life in women who use pessaries for longer than 12 months.
    Tenfelde S; Tell D; Thomas TN; Kenton K
    Female Pelvic Med Reconstr Surg; 2015; 21(3):146-9. PubMed ID: 25521465
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Women and healthcare providers' knowledge, attitudes and practice related to pessaries for pelvic organ prolapse: A Systematic review.
    Vasconcelos CTM; Silva Gomes ML; Ribeiro GL; Oriá MOB; Geoffrion R; Vasconcelos Neto JA
    Eur J Obstet Gynecol Reprod Biol; 2020 Apr; 247():132-142. PubMed ID: 32113060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attitudes toward pessary use among Thai women with pelvic organ prolapse.
    Mungpooklang T; Bunyavejchevin S
    J Obstet Gynaecol Res; 2017 Sep; 43(9):1449-1453. PubMed ID: 28833951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The characteristics and satisfaction of the patients using vaginal pessaries.
    Sitavarin S; Wattanayingcharoenchai R; Manonai J; Sarit-apirak S; Chittacharoen A
    J Med Assoc Thai; 2009 Jun; 92(6):744-7. PubMed ID: 19530578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.